Acción NEOPHARM CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas NeoPharm Co., Ltd. Korea S.E.

Acciones

Precio de cierre Korea S.E.
Otros sitios de cotización
- - Gráfico intradía de NeoPharm Co., Ltd.
2023 NeoPharm CO., LTD. Resultados del primer trimestre finalizado el 31 de marzo de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023
NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding
NeoPharm CO., LTD. announced that it expects to receive KRW 31.970667276 billion in funding
Gpower, inc. cancelled the acquisition of 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park.
Gpower, inc. agreed to acquire 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park for approximately KRW 780 million.
HOPE BIOSCIENCES, INC. Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from Neopharm Co. Ltd
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals.
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd from Yong-Chan Ahn and 7 individuals for KRW 72.8 billion.
Neopharm Co Ltd(KOSDAQ:A092730) added to S&P Global BMI Index
LEO Pharma A/S Enters Supply and Distribution Agreement with NeoPharm Co., Ltd. on Non-Prescription Skin Care Solutions
Neopharm Co Ltd's Equity Buyback announced on February 10, 2014 has expired.
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.
Neopharm Co Ltd authorizes a Buyback Plan.
Neopharm Co Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013
Neopharm Co Ltd s Equity Buyback announced on July 9, 2013 has expired with 166,483 shares for KRW 1,007.08 million.
Neopharm Co Ltd announces an Equity Buyback
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A092730
  4. Acción
  5. Noticias NeoPharm Co., Ltd.
  6. Otros idiomas